Diabetes & Metabolism Journal

Original Article

Others
Glycemic Benefit of Insulin Degludec/Insulin Aspart Compared to Basal Insulin in Type 2 Diabetes Mellitus Associated with Impaired Glucagon-Like Peptide-1 Response: A Randomized Crossover Trial: Han Na Jang, Eun Shil Hong, Ye Seul Yang, Seong Ok Lee, Myoung-jin Jang, Andrea Mari, Soo Heon Kwak, Kyong Soo Park, Hak Chul Jang, Hye Seung Jung; Received November 21, 2024 Accepted April 28, 2025 Published online August 14, 2025; DOI: https://doi.org/10.4093/dmj.2024.0741 [Epub ahead of print]

1,707 View
65 Download

Abstract PDF Supplementary Material PubReader ePub: Background
We aimed to confirm that once-daily insulin degludec/insulin aspart (IDegAsp) is superior to basal insulin therapy in participants with type 2 diabetes mellitus (T2DM) exhibiting signs of overbasalization. Additionally, we analyzed incretin profiles in relation to the benefits of IDegAsp, providing insights into the underlying mechanisms.
Methods
A prospective study was conducted in participants receiving basal insulin therapy, with a fasting plasma glucose (FPG) level lower than predicted from their glycosylated hemoglobin (HbA1c). Participants were randomly assigned to either IDegAsp or insulin glargine (IGlar) in a 1:1 ratio. After 20 weeks of treatment, the insulins were switched in a crossover design. The primary endpoint was the change in HbA1c from baseline. Incretin profiles, hypoglycemic events, and continuous glucose monitoring (CGM) were also analyzed (Trial registration: www.cris.nih.go.kr; KCT0004597).
Results
The study included 55 participants (male 40%, mean age 65 years, FPG 103 mg/dL, and HbA1c 8.3%). HbA1c significantly decreased to 7.8%±0.8% with IDegAsp, compared to 8.0%±0.7% with IGlar. The mean estimated treatment difference of changes was –0.21% points (95% confidence interval, –0.39 to –0.02; P=0.031), favoring IDegAsp. Hypoglycemic events were comparable. CGM demonstrated significantly lower glucose measures during the daytime with IDegAsp compared to IGlar, and vice versa at dawn. The HbA1c benefit of IDegAsp over IGlar was associated with a low glucagon-like peptide-1 (GLP-1) ratio at 30 minutes relative to baseline (r=0.301, P=0.040), while not with glucose-dependent insulinotropic polypeptide.
Conclusion
The greater reduction in HbA1c achieved with IDegAsp compared to IGlar in individuals with T2DM was associated with an impaired GLP-1 response, facilitating personalized insulin therapy.

Review

Complications
Pharmacological and Nonpharmacological Treatments for Painful Diabetic Peripheral Neuropathy: Han Na Jang, Tae Jung Oh; Diabetes Metab J. 2023;47(6):743-756. Published online September 6, 2023; DOI: https://doi.org/10.4093/dmj.2023.0018

44,663 View
1,896 Download
50 Web of Science
54 Crossref

Diabetic peripheral neuropathy (DPN) is one of the most prevalent chronic complications of diabetes. The lifetime prevalence of DPN is thought to be >50%, and 15%–25% of patients with diabetes experience neuropathic pain, referred to as “painful DPN.” Appropriate treatment of painful DPN is important because this pain contributes to a poor quality of life by causing sleep disturbance, anxiety, and depression. The basic principle for the management of painful DPN is to control hyperglycemia and other modifiable risk factors, but these may be insufficient for preventing or improving DPN. Because there is no promising diseasemodifying medication for DPN, the pain itself needs to be managed when treating painful DPN. Drugs for neuropathic pain, such as gabapentinoids, serotonin–norepinephrine reuptake inhibitors, tricyclic antidepressants, alpha-lipoic acid, sodium channel blockers, and topical capsaicin, are used for the management of painful DPN. The U.S. Food and Drug Administration (FDA) has approved pregabalin, duloxetine, tapentadol, and the 8% capsaicin patch as drugs for the treatment of painful DPN. Recently, spinal cord stimulation using electrical stimulation is approved by the FDA for the treatment for painful DPN. This review describes the currently available pharmacological and nonpharmacological treatments for painful DPN.

Citations

Citations to this article as recorded by

Advanced glycation end products mediated diabetic neuropathic pain via activation protein tyrosine phosphatase 1B in the spinal cord dorsal horn
Jing Wang, Xiao‐Qin Li, Rui‐Li Sun, Yu‐Hang Yang, Wen‐Jing Li, Yi‐Ke Shen, Jia‐Jia Wang, Zhi‐Xian Zhang, Qing‐Shan Yang, Shu‐Jin Wu
Diabetic Medicine.2026;[Epub] CrossRef
Neuropathic pain in diabetic patients: a review of pharmacological treatment selection according to psychopathological and somatic factors
Artur Reginia, Aleksandra Mazur, Agata Bąba-Kubiś, Marcin Jabłoński, Maciej Sołtysiński, Jerzy Samochowiec, Jolanta Kucharska-Mazur
Frontiers in Psychiatry.2026;[Epub] CrossRef
Immunological mechanisms and therapeutic advances in diabetic neuropathy
Suli Jiang, Linxiang Zhang, Lizhen Zhao, Yuchen Lv, Shaoyun Cheng, Cun Liu, Shengwei Xu, Bei Zhang
Journal of Neurology.2026;[Epub] CrossRef
Innovative strategies for diabetic peripheral neuropathy: From clinical management to emerging bioengineering solutions
Zhi He, Jie Diao, Frederick G. Hamel, Bin Duan
Bioactive Materials.2026; 61: 312. CrossRef
CCR2/CCR5 antagonism with cenicriviroc relieves neuropathic pain induced by sciatic nerve injury and delays morphine tolerance in mice
Anna Piotrowska, Joanna Starnowska-Sokół, Katarzyna Ciapała, Justyna Barut, Agata Ciechanowska, Klaudia Kwiatkowski, Ewelina Rojewska, Katarzyna Pawlik, Grzegorz Kreiner, Joanna Mika
Biochemical Pharmacology.2026; 247: 117773. CrossRef
Exercise training and balance function in middle-aged and older adults with diabetic peripheral neuropathy: a GRADE-based systematic review and meta-analysis
Rui Ma, Shuang Xu, Jianxin Kang, Xin Liu, Mingming Liu
Frontiers in Public Health.2026;[Epub] CrossRef
Diabetic peripheral neuropathy and neuromodulation techniques: a systematic review of progress and prospects
Rahul Mittal, Keelin McKenna, Grant Keith, Evan McKenna, Joana R. N. Lemos, Jeenu Mittal, Khemraj Hirani
Neural Regeneration Research.2025; 20(8): 2218. CrossRef
A comprehensive review on sustainable strategies for valorization of pepper waste and their potential application
Keithellakpam Sanatombi
Comprehensive Reviews in Food Science and Food Safety.2025;[Epub] CrossRef
Enhanced therapy for diabetic neuropathy utilizing venlafaxine hydrochloride-loaded transferosome-based transdermal gel
Kajol Patil, Pramod S. Salve, Ujban Md Hussain Hussain, Amol Tatode, Mohammad Qutub
Nano Trends.2025; 9: 100085. CrossRef
Fast Analgesic Effect in Response Test with Topical Phenytoin Cream Correlates with Prolonged Pain Relief After Extended Use in Painful Diabetic Neuropathy
David J. Kopsky, Alexander F. J. E. Vrancken, Ruben P. A. van Eijk, Ricardo Alvarez-Jimenez, Karolina M. Szadek, Remko Liebregts, Monique A. H. Steegers
Pharmaceuticals.2025; 18(2): 228. CrossRef
High‐Field Diffusion Tensor Imaging of Median, Tibial, and Sural Nerves in Type 2 Diabetes With Morphometric Analysis
Luka Pušnik, Aljoša Gabor, Barbora Radochová, Jiří Janáček, František Saudek, Armin Alibegović, Igor Serša, Erika Cvetko, Nejc Umek, Žiga Snoj
Journal of Neuroimaging.2025;[Epub] CrossRef
Neuropathic pain management: a focused review of current treatments and novel data from main ongoing clinical trials
Nikola Andrejic, Ivo Božovic, Hadi Moradi, Rojin Tataei, Nebojsa Nick Knezevic
Expert Opinion on Investigational Drugs.2025; 34(4): 287. CrossRef
Comprehensive approach to the rehabilitation of professionals with high levels of psychophysical stress, pain syndromes and type 2 diabetes mellitus during the war
Lidiia V. Butska, Oksana O. Drevitska, Sergei V. Dybkalyuk, Valentyn O. Ryzhak
Polski Merkuriusz Lekarski.2025; 53(1): 34. CrossRef
Role of Mitochondrial Dysfunction in Neuropathy
Nidia Espinoza, Vassilios Papadopoulos
International Journal of Molecular Sciences.2025; 26(7): 3195. CrossRef
Commentary: Analysis of risk factors for painful diabetic peripheral neuropathy and construction of a prediction model based on Lasso regression
Bingdi Wei, Yao Liu, Xiaorui Liu, Chaojun Wei
Frontiers in Endocrinology.2025;[Epub] CrossRef
Sigma-1 receptor as an emerging target for painful diabetic neuropathy—a review
Youyi Peng, Qiang Zhang, Shan Chen
Exploration of Neuroscience.2025;[Epub] CrossRef
Klinische Pharmakologie von Opioidanalgetika
Constanze Rémi, Jennifer Berner, Aleksandra Dukic-Ott, Christina Hepperle
Der Schmerz.2025; 39(4): 287. CrossRef
Alpha-Tocopherol-Loaded Liposomes Reduce High Glucose Induced Oxidative Stress in Schwann Cells: A Proof of Concept Study
Jee-In Heo, Mi Jeong Kim, Daehyun Kim, Jimin Seo, Joon Ho Moon, Sung Hee Choi, Hak Jong Lee, Tae Jung Oh
Diabetes & Metabolism Journal.2025; 49(3): 507. CrossRef
Editorial for CASPAR: a retrospective cohort study of the high-concentration capsaicin topical system in patients with painful diabetic peripheral neuropathy of the feet
Sanjeev Sharma
BMJ Open Diabetes Research & Care.2025; 13(3): e005098. CrossRef
Repetitive transcranial magnetic stimulation ameliorates chronic pain behavior and modulates the brain transcriptome in a mouse model of chronic constriction injury
Tianying Li, Guanwen Lin, Tao Zhang, Yani Guo, Yongjin He, Jing Luan, Jin Wang, Dan Lyu, Yiqi Weng, Xin Jin
Brain Research Bulletin.2025; 227: 111383. CrossRef
Peripheral Neuropathy in Patients With Ovarian Cancer Administrating Poly ADP-Ribose Polymerase Inhibitors: A Real-World Study Based on Bayesian Disproportionality Analysis of the US Food and Drug Administration Adverse Event Reporting System
Chenguang Yang, Xuan Song, Hongmei Sun, Xi Chen, Chengjiang Liu, Yi Yang, Zhongjian Wang, Jing Zhu, Min Chen
Clinical Therapeutics.2025; 47(9): 673. CrossRef
10 kHz spinal cord stimulation vs. traditional low-frequency spinal cord stimulation for the treatment of diabetes peripheral neuropathic pain: study protocol for a multi-center randomized controlled clinical trial
Chen Li, Chun-Hua Liu, Yi-Fan Li, Hui-Min Hu, Qing Shi, An-Xiang Liu, Wen-Hui Liu, Yi Zhang, Peng Mao, Bi-Fa Fan
Frontiers in Neurology.2025;[Epub] CrossRef
Early diagnosis and effective therapy of diabetic polyneuropathy
L.T. Akhmedzhanova, E.V. Mandra, E.S. Shulakova, O.A. Solokha
S.S. Korsakov Journal of Neurology and Psychiatry.2025; 125(5): 62. CrossRef
Identification and validation of serum amino acids as diagnostic biomarkers for diabetic peripheral neuropathy
Wei-Sheng Xu, Huan Xing, Qing-Qing Wang, Hui Qi, Jian-Tao He, Tong Jin, Yan-Peng Kan, Shi-Yu Sun, Ji-Ying Wang, Fu-Qing Lin
World Journal of Diabetes.2025;[Epub] CrossRef
Exploring molecular genetics and gene editing approaches of peripheral neuropathies: A future treatment approach
Fatima Muzamil, Muhammad Waseem Sajjad
Gene Reports.2025; 40: 102285. CrossRef
Clinical Phenotypes of Diabetic Peripheral Neuropathy: Implications for Phenotypic-Based Therapeutics Strategies
Jie-Eun Lee, Jong Chul Won
Diabetes & Metabolism Journal.2025; 49(4): 542. CrossRef
Long-lasting and fast methylglyoxal-scavenging peptide CycK(Myr)R4E alleviates chronic pain in type 2 diabetic mice
Paramita Basu, Diogo F. S. Santos, Nina Gakii, Margaret R. Gralinski, Ryan B. Griggs, Sebastian Brings, Thomas Fleming, Keiichiro Susuki, Bradley K. Taylor
PAIN Reports.2025; 10(5): e1312. CrossRef
Neuroprotective Activity of Eriodictyol Against Streptozotocin-Induced Diabetic Peripheral Neuropathy in Wistar Rats by Targeting Wnt/β-Catenin Pathway
Renu Malik, Balvinder Singh, Ajay Singh Kushwah, Manish Kumar
NeuroMolecular Medicine.2025;[Epub] CrossRef
Therapeutic potential of melatonin in management of diabetic mellitus and diabetic neuropathic pain: Underlying mechanisms, challenges and future perspectives
Yaswanth Kuthati, Vaikar Navakanth Rao, Lokesh Kumar Mende, Chih-Shung Wong
Journal of the Formosan Medical Association.2025;[Epub] CrossRef
Mitochondrial DNA Stress Promotes the Ferroptosis of Endothelial Cells in Diabetic Peripheral Neuropathy by Upregulating ALOX15
Xuan Zhang, Yu Yue, Ling Zhang, Zhiqun Mou
Critical Reviews in Eukaryotic Gene Expression.2025; 35(6): 27. CrossRef
Painful diabetic neuropathy complicated with secondary erythromelalgia in polycythemia vera: A case report
Hong Zhang, Zhengran Qin, Xiaohong Feng
Journal of International Medical Research.2025;[Epub] CrossRef
Comprehensive insights into diabetic peripheral neuropathy: pathophysiology and therapeutic approaches
Sumit Kumar, Vandana Arora Sethi, Chitra Gupta
Journal of Diabetes & Metabolic Disorders.2025;[Epub] CrossRef
CONTRIBUIÇÕES DA NUTRACÊUTICA CLÍNICA NO TRATAMENTO DO DIABETES TIPO II E OBESIDADE: UMA REVISÃO INTEGRATIVA
Jeanete Carolina Horst Maciel, Marcelo da Costa Pereira , Eliana de Souza Serna , Margareth Pereira Dias , Valter Dias da Silva
Revista OMNIA Saúde.2025; 8(esp.): 98. CrossRef
Mechanism-driven multitarget therapeutics for diabetic peripheral neuropathy
Shiyu Kong, Guanglei Nan, Yueyang Wang, Mingyan Du, Yuanfang Kong, Lifeng Zhu, Xu Shen, Xiaofei Li, Chunhong Dong
Neuroscience.2025; 590: 150. CrossRef
Efficacy and Safety of Roflumilast versus Alpha-Lipoic Acid in Type 2 Diabetes with Neuropathy: A Comparative Clinical Study
Asmaa Elsharab, Mohamed Nooh, Raghda Matard, Tarek Mostafa, Dalia El-Afify
Diabetes, Metabolic Syndrome and Obesity.2025; Volume 18: 4193. CrossRef
Diabetic Neuropathy Improved with Korean Medicine Combination Therapy Including KyungHee Gongjin-dan: A Case Report
Kyeong-Hwa Heo, Dong-Joo Kim, Min-Jae Kwak, Na-Yeon Kim, Chang-Nam Ko, Seong-Uk Park, Seung-Yeon Cho, Jung-Mi Park
The Journal of Internal Korean Medicine.2025; 46(5): 1215. CrossRef
Chitosan Protects Peripheral Nerves Against Damage Induced by Diabetes Mellitus
Anca-Maria Țucă, Carmen Albu, Alexandra Nicoleta Preda, Alexandra Oltea Dan, Elena-Anca Târtea, Andrei Greșiță, Denisa Floriana Vasilica Pîrșcoveanu, Veronica Sfredel, Smaranda Ioana Mitran, Georgică Târtea
Life.2025; 15(12): 1860. CrossRef
Development and validation of a risk prediction model for painful diabetic peripheral neuropathy in type 2 diabetes mellitus: a multicenter retrospective study
Yanpi Li, Xiyun Wang, Huimin Hu, Xinyi Zhou, Naichong Hu, Wenhui Liu, Yi Zhang, Peng Mao, Liyuan Xu, Qian Zhu, Bifa Fan, Yifan Li
Frontiers in Endocrinology.2025;[Epub] CrossRef
Biomarkers and Novel Therapies of Diabetic Neuropathy: An Updated Review
Namra Aziz, Shital Vijay Nehere, Rishika Sinha, Rajeev Satyarthy, Harshit Prajapati, Uttam Prasad Panigrahy, Mukesh Chandra Sharma, Pankaj Kumar, Pranay Wal
Current Pharmaceutical Biotechnology.2025; 26(14): 2320. CrossRef
Dapagliflozin Preserves Peripheral Nerve Structure and Reduces Neuropathic Damage in Streptozotocin-Induced Diabetic Peripheral Neuropathy
Anca-Maria Țucă, Alexandra Nicoleta Preda, Georgică Târtea, Diana-Ruxandra Hădăreanu, Eugen Țieranu, Alexandra Oltea Dan, Elena-Anca Târtea, Andrei Greșiță, Denisa Floriana Vasilica Pîrșcoveanu, Veronica Sfredel, Smaranda Ioana Mitran
International Journal of Molecular Sciences.2025; 26(24): 12034. CrossRef
J-2156, a small molecule somatostatin type 4 receptor agonist, alleviated hindpaw hypersensitivity in the streptozotocin-induced rat model of painful diabetic neuropathy but with a 2-fold decrease in potency at an advanced stage in the model, mimicking mo
A. Kuo, M. Z. Imam, R. Li, L. Lin, A. Raboczyj, A. E. Bohmer, J. R. Nicholson, L. Corradini, M. T. Smith
Frontiers in Pharmacology.2024;[Epub] CrossRef
The Chronic Wound–Related Pain Model
Kevin Woo
Clinics in Geriatric Medicine.2024; 40(3): 501. CrossRef
Diabetic Neuropathy: A Guide to Pain Management
Emily X. Zhang, Cyrus Yazdi, Rahib K. Islam, Ahmed I. Anwar, Alana Alvares-Amado, Horace Townsend, Kaitlyn E. Allen, Elena Plakotaris, Jon D. Hirsch, Ross G. Rieger, Varsha Allampalli, Jamal Hasoon, Kazi N. Islam, Sahar Shekoohi, Alan D. Kaye, Christopher
Current Pain and Headache Reports.2024; 28(10): 1067. CrossRef
Expert opinion on screening, diagnosis and management of diabetic peripheral neuropathy: a multidisciplinary approach
Aysegul Atmaca, Aysegul Ketenci, Ibrahim Sahin, Ihsan Sukru Sengun, Ramazan Ilyas Oner, Hacer Erdem Tilki, Mine Adas, Hatice Soyleli, Tevfik Demir
Frontiers in Endocrinology.2024;[Epub] CrossRef
Predicting the efficacy of rehabilitation in patients with type 2 diabetes and diabetic polyneuropathy
T.H. Bakaliuk, N.R. Makarchuk, H.O. Stelmakh, V.I. Pankiv, I.I. Kamyshna
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2024; 20(3): 155. CrossRef
Xiaoke Bitong capsule alleviates inflammatory impairment via inhibition of the TNF signaling pathway to against diabetic peripheral neuropathy
Lulu Tian, Meiqi Yang, Shanjie Tu, Kaixin Chang, Huanyu Jiang, Yuwei Jiang, Lu Ding, Zhiwei Weng, Yueqiang Wang, Xiaolong Tan, Chunxiao Zong, Buyang Chen, Xiaobing Dou, Xiuge Wang, Xuchen Qi
Phytomedicine.2024; 132: 155867. CrossRef
Exploring the Efficacy of Alpha-Lipoic Acid in Comorbid Osteoarthritis and Type 2 Diabetes Mellitus
Iryna Halabitska, Valentyn Oksenych, Oleksandr Kamyshnyi
Nutrients.2024; 16(19): 3349. CrossRef
Research Progress of Coenzyme Q in Diabetes Mellitus and Its Common Complications
Jingdong Xia, Xiudan Li, Chunying Bai, Xuchen Han
Diabetes, Metabolic Syndrome and Obesity.2024; Volume 17: 3629. CrossRef
Negative allosteric modulator of Group Ⅰ mGluRs: Recent advances and therapeutic perspective for neuropathic pain
Jia-Ling Li, Chun-Hao Zhu, Miao-Miao Tian, Yue Liu, Lin Ma, Li-Jun Tao, Ping Zheng, Jian-Qiang Yu, Ning Liu
Neuroscience.2024; 560: 406. CrossRef
A Missing Puzzle in Preclinical Studies—Are CCR2, CCR5, and Their Ligands’ Roles Similar in Obesity-Induced Hypersensitivity and Diabetic Neuropathy?—Evidence from Rodent Models and Clinical Studies
Aleksandra Bober, Joanna Mika, Anna Piotrowska
International Journal of Molecular Sciences.2024; 25(20): 11323. CrossRef
Bibliometric and visualized analysis of 2014–2024 publications on therapy for diabetic peripheral neuropathy
Baitian Fu, Ning Luo, Yichen Zeng, Yutian Chen, Low Je Wie, Jianqiao Fang
Frontiers in Neuroscience.2024;[Epub] CrossRef
The neuroprotective effects of progesterone against peripheral neuropathy: a systematic review of non-clinical studies
Hamed Haghi-Aminjan, Mahsa Kouhestani, Asieh Hosseini
Metabolic Brain Disease.2024;[Epub] CrossRef
The irreversible, towards fatalic neuropathy: from the genesis of diabetes
Bhaskar Pal, Rashmi Ghosh, Raktimava Das Sarkar, Gouranga Sundar Roy
Acta Diabetologica.2024; 62(2): 139. CrossRef
Transcutaneous Electrical Nerve Stimulation and Aerobic Exercise for Alcohol-Related Peripheral Neuropathy: A Case Report
Yuto Niwa, Manabu Nankaku, Ryosuke Ikeguchi
Cureus.2024;[Epub] CrossRef

Original Article

Complications
Prevalence of Diabetic Retinopathy in Undiagnosed Diabetic Patients: A Nationwide Population-Based Study: Han Na Jang, Min Kyong Moon, Bo Kyung Koo; Diabetes Metab J. 2022;46(4):620-629. Published online February 23, 2022; DOI: https://doi.org/10.4093/dmj.2021.0099

9,032 View
252 Download
13 Web of Science
14 Crossref

Abstract PDF Supplementary Material PubReader ePub

Background
We investigated the prevalence of diabetic retinopathy (DR) in patients with undiagnosed diabetes through a nationwide survey, compared to those with known diabetes.
Methods
Among the participants of the Korean National Health and Nutrition Examination Surveys (KNHANES) from 2017 to 2018, individuals aged ≥40 years with diabetes and fundus exam results were enrolled. Sampling weights were applied to represent the entire Korean population. Newly detected diabetes patients through KNHANES were classified under “undiagnosed diabetes.”
Results
Among a total of 9,108 participants aged ≥40 years, 951 were selected for analysis. Of them, 31.3% (standard error, ±2.0%) were classified under “undiagnosed diabetes.” The prevalence of DR in patients with known and undiagnosed diabetes was 24.5%±2.0% and 10.7%±2.2%, respectively (P<0.001). The DR prevalence increased with rising glycosylated hemoglobin (HbA1c) levels in patients with known and undiagnosed diabetes (P for trend=0.001 in both). Among those with undiagnosed diabetes, the prevalence of DR was 6.9%±2.1%, 8.0%±3.4%, 5.6%±5.7%, 16.7%±9.4%, and 42.6%±14.8% for HbA1c levels of <7.0%, 7.0%–7.9%, 8.0%–8.9%, 9.0%–9.9%, and ≥10.0% respectively. There was no difference in the prevalence of hypertension, dyslipidemia, hypertriglyceridemia, or obesity according to the presence or absence of DR.
Conclusion
About one-third of patients with diabetes were unaware of their diabetes, and 10% of them have already developed DR. Considering increasing the prevalence of DR according to HbA1c level was found in patients with undiagnosed diabetes like those with known diabetes, screening and early detection of diabetes and DR are important.

Citations

Citations to this article as recorded by

Retinal OCT-Derived Texture Features as Potential Biomarkers for Early Diagnosis and Progression of Diabetic Retinopathy
Sara Oliveira, Pedro Guimarães, Elisa Julião Campos, Rosa Fernandes, João Martins, Miguel Castelo-Branco, Pedro Serranho, Paulo Matafome, Rui Bernardes, António Francisco Ambrósio
Investigative Ophthalmology & Visual Science.2025; 66(1): 7. CrossRef
Frequency and Pattern of Retinopathy in Newly Diagnosed Type 2 Diabetic Patients
Faisal Mehmood, Syed Abdullah Mazhar, Nesr Farooq, Muhammad Awais Afzal
Pakistan Journal of Health Sciences.2025; : 197. CrossRef
Retinal Biomarkers in Diabetic Retinopathy: From Early Detection to Personalized Treatment
Georgios Chondrozoumakis, Eleftherios Chatzimichail, Oussama Habra, Efstathios Vounotrypidis, Nikolaos Papanas, Zisis Gatzioufas, Georgios D. Panos
Journal of Clinical Medicine.2025; 14(4): 1343. CrossRef
Detection Rate of Diabetic Retinopathy Before and After Implementation of Autonomous AI-based Fundus Photograph Analysis in a Resource-Limited Area in Belize
Houri Esmaeilkhanian, Karen Gutierrez, David Myung, Ann Fisher
Clinical Ophthalmology.2025; Volume 19: 993. CrossRef
Análisis de la prevalencia de la retinopatía diabética en un programa de cribado por telemedicina durante el periodo 2018 a 2023
Ó. García-Espinilla, P. Arlanzón-Lope, A. Novo-Díez, D.R. Llanos Ferraris, S. Ortiz-Toquero, P. de la Iglesia Rodríguez, M. López-Gálvez, J.C. Pastor
Archivos de la Sociedad Española de Oftalmología.2025; 100(7): 377. CrossRef
What do You Need to Know after Diabetes and before Diabetic Retinopathy?
Shiyu Zhang, Jia Liu, Heng Zhao, Yuan Gao, Changhong Ren, Xuxiang Zhang
Aging and disease.2025;[Epub] CrossRef
Analysis of the prevalence of diabetic retinopathy in a telemedicine screening programme from 2018 to 2023
Ó. García-Espinilla, P. Arlanzón-Lope, A. Novo-Díez, D.R. Llanos-Ferraris, S. Ortiz-Toquero, P. de la Iglesia-Rodríguez, M. López-Gálvez, J.C. Pastor-Jimeno
Archivos de la Sociedad Española de Oftalmología (English Edition).2025; 100(7): 377. CrossRef
The Prevalence of Diabetic Retinopathy in the 21st Century: New Insights From a Portuguese Center
Pedro Moreira Martins, Sara Leite, Sofia Teixeira, João Castro Cabanas, Luís Silva, Filipe Sousa-Neves
Cureus.2025;[Epub] CrossRef
Early retinal changes in type 2 diabetes detected by texture-based OCT analysis: potential approach for subclinical diabetic retinopathy diagnosis
Sara Oliveira, Pedro Guimarães, Ângelo Roque-Rosado, Elisa Julião Campos, Pedro Serranho, Paulo Matafome, Rui Bernardes, António Francisco Ambrósio
Eye and Vision.2025;[Epub] CrossRef
Risk factors of peripheral occlusive arterial disease in patients with diabetic retinopathy due to type 2 diabetes
Milos Maksimovic
Srpski arhiv za celokupno lekarstvo.2024; 152(1-2): 50. CrossRef
Gene Expression Analysis in T2DM and Its Associated Microvascular Diabetic Complications: Focus on Risk Factor and RAAS Pathway
Laxmipriya Jena, Prabhsimran Kaur, Tashvinder Singh, Kangan Sharma, Sushil Kotru, Anjana Munshi
Molecular Neurobiology.2024; 61(11): 8656. CrossRef
Trends and Barriers in Diabetic Retinopathy Screening: Korea National Health and Nutritional Examination Survey 2016–2021
Min Seok Kim, Sang Jun Park, Kwangsic Joo, Se Joon Woo
Journal of Korean Medical Science.2024;[Epub] CrossRef
Novel Asian-Specific Visceral Adiposity Indices Are Associated with Chronic Kidney Disease in Korean Adults
Jonghwa Jin, Hyein Woo, Youngeun Jang, Won-Ki Lee, Jung-Guk Kim, In-Kyu Lee, Keun-Gyu Park, Yeon-Kyung Choi
Diabetes & Metabolism Journal.2023; 47(3): 426. CrossRef
Prevalence of osteosarcopenic obesity and related factors among Iranian older people: Bushehr Elderly Health (BEH) program
Mozhgan Ahmadinezhad, Mohammad Ali Mansournia, Noushin Fahimfar, Gita Shafiee, Iraj Nabipour, Mahnaz Sanjari, Kazem Khalagi, Mohammad Javad Mansourzadeh, Bagher Larijani, Afshin Ostovar
Archives of Osteoporosis.2023;[Epub] CrossRef

First
Prev
Page of 1
Next
Last

Search